biguanides has been researched along with Atherogenesis in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Individuals with type 2 diabetes (T2DM) are at increased risk of cardiovascular disease, including heart failure (HF)." | 1.39 | Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes. ( Czlonkowski, A; Filipiak, KJ; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Rosiak, M; Trzepla, E, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babenko, AY | 1 |
| Savitskaya, DA | 1 |
| Kononova, YA | 1 |
| Trofimova, AY | 1 |
| Simanenkova, AV | 1 |
| Vasilyeva, EY | 1 |
| Shlyakhto, EV | 1 |
| Rosiak, M | 1 |
| Postula, M | 1 |
| Kaplon-Cieslicka, A | 1 |
| Trzepla, E | 1 |
| Czlonkowski, A | 1 |
| Filipiak, KJ | 1 |
| Opolski, G | 1 |
2 other studies available for biguanides and Atherogenesis
| Article | Year |
|---|---|
Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity.
Topics: Adult; Aged; Atherosclerosis; Biguanides; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes M | 2019 |
Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Aged; Atherosclerosis; Biguanides; Cardiovascular Diseases; Coronary Ar | 2013 |